EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Direct Testing of Blood Samples to Diagnose Bloodstream Infections

Xiaoyi Yang iD, Yiyang Fan, Xin Xu iD, Tong Shen, Xiaohui An, Yuting Zhang, Ze Zhang, Hongzhi Pan iD, Dong Chang

ACS Infectious Diseases · 2025

DOI: 10.1021/acsinfecdis.5c00109 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Infectious Diseases, 2025. Verfasst von Xiaoyi Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai 201399, China. Hauptthemen laut MEDLINE: Molecular Diagnostic Techniques, Sepsis, Bacteremia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 143 Literaturangaben. Gefördert von: Fudan University, National Natural Science Foundation of China, Health and Family Planning Committee of Pudong New Area.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bloodstream infection (BSI) is a critical condition with extremely high mortality. Rapid and accurate diagnosis is crucial for effective treatment. The traditional blood culture (BC) method has issues, such as long testing times and limited sensitivity, making it challenging to meet the need for timely diagnosis. To address this problem, various molecular biology methods for directly detecting blood samples (whole blood, plasma, serum, and positive BC samples) have emerged. These include Raman spectroscopy, mass spectrometry, nucleic acid amplification, and hybridization techniques (such as the CRISPR/Cas system, digital droplet PCR (ddPCR), and T2 magnetic resonance (T2MR)), biosensors, and next-generation sequencing (NGS). These methods can quickly identify pathogens and their drug-resistant markers, significantly reducing diagnostic delays and helping to provide earlier targeted treatment. This article systematically analyzes the principles, advantages, and disadvantages of these advanced techniques, explores their value in revolutionizing the BSI diagnostic model, and looks ahead to future development directions, providing a reference for research and clinical applications in this field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Diagnostic TechniquesSepsisBacteremiaHumansHigh-Throughput Nucleotide SequencingBlood CultureSpectrum Analysis, RamanBiosensing Techniques

Stichwörter der Autor:innen

CRISPR/Cas systemNGSPOCTbiosensorbloodstream infection

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai 201399, China.
  • Collaborative Research Center, Shanghai University of Medicine and Health Sciences, Shanghai 201399, China.

ORCID-Profile: Xiaoyi Yang, Xin Xu, Hongzhi Pan

Förderung

  • Fudan University
  • National Natural Science Foundation of China
  • Health and Family Planning Committee of Pudong New Area
  • Fudan Zhangjiang Clinical Innovation Fund Project
  • Shanghai Pudong Hospital Institute

Zitieren

APA

Yang, X., Fan, Y., Xu, X., Shen, T., An, X., Zhang, Y., Zhang, Z., Pan, H., & Chang, D. (2025). Direct Testing of Blood Samples to Diagnose Bloodstream Infections. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.5c00109

Vancouver

Yang X, Fan Y, Xu X, Shen T, An X, Zhang Y, et al. Direct Testing of Blood Samples to Diagnose Bloodstream Infections. ACS Infectious Diseases. 2025. doi:10.1021/acsinfecdis.5c00109

BibTeX
@article{Yang2025,
  author = {Yang, Xiaoyi and Fan, Yiyang and Xu, Xin and Shen, Tong and An, Xiaohui and Zhang, Yuting and Zhang, Ze and Pan, Hongzhi and Chang, Dong},
  title = {Direct Testing of Blood Samples to Diagnose Bloodstream Infections},
  journal = {ACS Infectious Diseases},
  year = {2025},
  doi = {10.1021/acsinfecdis.5c00109}
}
Kostenlos starten →